Dynamic changes of intracellular signals in ATTR Tyr114Cys amyloidosis

Hereditary transthyretin (TTR) amyloidosis (ATTRv amyloidosis) is an autosomal dominant disease caused by various TTR mutations. Despite the fact that ATTR Tyr114Cys (p.Tyr134Cys) amyloidosis (tyrosine to cysteine at codon 114) exhibits poorer prognosis than other ATTRv amyloidosis and leads to deat...

Full description

Bibliographic Details
Published in:	Biochemistry and Biophysics Reports
Main Authors:	Kenta Ouchi, Takeshi Masuda, Kou Yonemaru, Kaori Isono, Yuki Ohya, Nobuaki Shiraki, Masayoshi Tasaki, Yukihiro Inomata, Mitsuharu Ueda, Takumi Era, Shoen Kume, Yukio Ando, Hirofumi Jono
Format:	Article
Language:	English
Published:	Elsevier 2025-06-01
Subjects:	ATTR amyloidosis Transthyretin Induced pluripotent stem cells Proteomic analysis
Online Access:	http://www.sciencedirect.com/science/article/pii/S2405580825000998

Similar Items

Characterization of heterozygous ATTR Tyr114Cys amyloidosis-specific induced pluripotent stem cells
by: Kenta Ouchi, et al.
Published: (2024-01-01)

ATTR Epidemiology, Genetics, and Prognostic Factors
by: Chukwuemeka A. Obi, et al.
Published: (2022-03-01)

Delays in diagnosis and treatment of ATTR cardiac amyloidosis: A real‐world data analysis
by: Julia Vogel, et al.
Published: (2025-08-01)

Familial amyloid polyneuropathy TTR Cys 114 in monozygotic twin brothers (clinical case)
by: M. O. Kovalchuk, et al.
Published: (2017-05-01)

Best Practices in Nuclear Imaging for the Diagnosis of Transthyretin Amyloid Cardiomyopathy (ATTR-CM) in KSA: The Eagle Eyes of Local Experts
by: Abdullah Alqarni, et al.
Published: (2024-01-01)

World Heart Federation Consensus on Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM)
by: Dulce Brito (Chair), et al.
Published: (2023-10-01)

Urinary Transthyretin as a Biomarker in ATTRv Val50Met Amyloidosis
by: Hiroaki Matsushita, et al.
Published: (2022-06-01)

«Red flags» en pacientes con polineuropatía amiloidótica familiar relacionada con transtiretina (hATTR) en el momento del diagnóstico en un área no endémica de España
by: L. Silva-Hernández, et al.
Published: (2023-03-01)

Rare variant (p.Ser43Asn) of familial transthyretin amyloidosis associated with isolated cardiac phenotype: A case series with literature review
by: Maria Papathanasiou, et al.
Published: (2021-12-01)

Specific therapeutic options for transthyretin amyloidosis
by: Zoltán Pozsonyi
Published: (2024-12-01)

Reliability and validity of the Transthyretin Amyloidosis – Quality of Life (ATTR-QOL) Questionnaire impact scales
by: Andrew Lovley, et al.
Published: (2025-04-01)

The journey to diagnosis of wild-type transthyretin-mediated (ATTRwt) amyloidosis: a path with multisystem involvement
by: Chafic Karam, et al.
Published: (2024-11-01)

Six-minute walk test as clinical end point in cardiomyopathy clinical trials, including ATTR-CM: a systematic literature review
by: Jose Nativi-Nicolau, et al.
Published: (2024-06-01)

Hereditary cardiac amyloidosis associated with Pro24Ser transthyretin mutation: a case report
by: Hiroyuki Yamamoto, et al.
Published: (2018-12-01)

Tafamidis treatment in patients with transthyretin amyloid cardiomyopathy: a systematic review and meta-analysisResearch in context
by: Jie Wang, et al.
Published: (2023-09-01)

ATTR Variant Amyloidosis in Patients with Dysphagia
by: Christina Hui Lee Ng, et al.
Published: (2023-06-01)

Bone scintigraphy imaging of cardiac amyloidosis
by: Issa Menge Kuria, et al.
Published: (2019-07-01)

Advances in the treatment of hereditary transthyretin amyloidosis: A review
by: Morie A. Gertz, et al.
Published: (2019-09-01)

Systemic ATTR-amyloidosis, a Rare Form of Internal Organ Damage
by: V. V. Rameev, et al.
Published: (2019-07-01)

Unravelling the myriad physiologic roles of transthyretin: critical considerations for treating transthyretin amyloidosis
by: Morie A. Gertz, et al.
Published: (2025-12-01)

Phenotypic heterogeneity and diagnostic features of transthyretin amyloidosis with polyneuropathy
by: S. S. Nikitin, et al.
Published: (2021-12-01)

Oligomerization Profile of Human Transthyretin Variants with Distinct Amyloidogenicity
by: Ana Frangolho, et al.
Published: (2020-12-01)

The application of biomarkers in hereditary transthyretin amyloidosis – an ongoing research project on bulgarian patients
by: Z. Pavlova, et al.
Published: (2024-04-01)

Role of Diphosphonates Bone Scintigraphy in Correlation with Biomarkers for a Personalized Approach to ATTR Cardiac Amyloidosis in North-Eastern Romania
by: Teodor Marian Ionescu, et al.
Published: (2022-12-01)

Generation of familial amyloidotic polyneuropathy-specific induced pluripotent stem cells
by: Kaori Isono, et al.
Published: (2014-03-01)

A Clinical Case of the Hereditary Transthyretin Amyloidosis
by: E. V. Reznik, et al.
Published: (2021-05-01)

A General Overview of Transthyretin Cardiac Amyloidosis and Summary of Expert Opinions on Pre-Symptomatic Testing and Management of Asymptomatic Patients with a Focus on Transthyretin V122I
by: Khalid Sawalha, et al.
Published: (2025-02-01)

Biochemical and biophysical properties of a rare TTRA81V mutation causing mild transthyretin amyloid cardiomyopathy
by: Qiuyan Sha, et al.
Published: (2024-02-01)

Dapagliflozin treatment and cardiovascular outcome in RBP4/TTRVal30Met (transthyretin cardiac amyloidosis) mice
by: Zonglin Li, et al.
Published: (2024-02-01)

Advances in understanding, diagnosis and targeting ATTR cardiomyopathy: a review
by: Maria Kulak, et al.
Published: (2024-06-01)

Patisiran in hATTR Amyloidosis: Six-Month Latency Period before Efficacy
by: Luca Gentile, et al.
Published: (2021-04-01)

Benefits of Patisiran on Functional Capacity in ATTR Cardiac Amyloidosis
by: John L. Berk, MD, et al.
Published: (2025-08-01)

Unraveling gut microbiome alterations and metabolic signatures in hereditary transthyretin amyloidosis
by: Hanyu Li, et al.
Published: (2025-07-01)

Prevalence estimation of ATTRv in China based on genetic databases
by: Zheng Yongsheng, et al.
Published: (2023-04-01)

利用泛素分裂系统筛选AtTR1相互作用蛋白质
by: 张亚, et al.
Published: (2013-01-01)

Diagnostic utility of semi-quantitative planar scintigraphy in ATTR cardiac amyloidosis: timepoint analysis and extracardiac tracer distribution
by: Aiganym Imakhanova, et al.
Published: (2026-04-01)

Contemporary Description of Clinical Characteristics and Outcomes in Patients with Hereditary ATTR Amyloidosis: Results from the Multicountry OverTTuRe Study
by: Kevin M. Alexander, et al.
Published: (2026-05-01)

Systemic amyloidosis in a patient with acute heart failure
by: E. V. Shekhovtsova, et al.
Published: (2024-08-01)

Small intestinal bacterial overgrowth in variant transthyretin amyloidosis (A-ATTRv)
by: Ana Moreno García, et al.
Published: (2025-05-01)

Optimizing cardiac amyloidosis assessment: utility of 1-h and 3-h 99mTc-PYP imaging
by: Aiganym Imakhanova, et al.
Published: (2024-01-01)